Showing results (1721-1730 of 1,875) with videos related to

Sort By:
Pageof 188
Emerging Infectious Diseases|June 8, 2007
Chikungunya virus, Cameroon, 2006Christophe N Peyrefitte, Dominique Rousset, Boris A M Pastorino, et al.
Bulletin Du Cancer|January 30, 2026
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer]Cyrus Chargari, Alejandra Martinez, Judith Michels, et al.
Frontiers in Pharmacology|January 20, 2022
The Glutathione Metabolite γ-Glutamyl-Glutamate Partially Activates Glutamate NMDA Receptors in Central Neurons With Higher Efficacy for GluN2B-Containing ReceptorsFatiha Sebih, Nawfel Mokrane, Pierre Fontanel, et al.
Epilepsia|March 30, 2026
Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injuryHadassa Kwetsie, Inge M W Verberk, Jans S van Ool, et al.
Bulletin Du Cancer|September 10, 2025
[Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors]Sil Endale Ahanda, Alexandra Lainé, Brunhilde Hanvic, et al.
Journal of Gynecology Obstetrics and Human Reproduction|November 4, 2020
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservationNicolas Bourdel, Cyrille Huchon, Cendos Abdel Wahab, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|November 13, 2018
[Contraception: CNGOF Guidelines for Clinical Practice (Short Version)]N Chabbert-Buffet, H Marret, A Agostini, et al.
Gynecologic Oncology|October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 studyF Gernier, A Gompel, C Rousset-Jablonski, et al.
American Journal of Respiratory and Critical Care Medicine|March 21, 2014
Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infectionAmélie Guihot, Charles-Edouard Luyt, Antoine Parrot, et al.
Cancer Cell|May 16, 2019
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome ActivationMercedes Segovia, Sofia Russo, Mathias Jeldres, et al.
Pageof 188